These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells. Zhu HJ; Liu L; Fan L; Zhang LN; Fang C; Zou ZJ; Li JY; Xu W Leuk Lymphoma; 2013 Dec; 54(12):2712-9. PubMed ID: 23517560 [TBL] [Abstract][Full Text] [Related]
3. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways. Saha MN; Jiang H; Chang H Cancer Biol Ther; 2010 Sep; 10(6):567-78. PubMed ID: 20595817 [TBL] [Abstract][Full Text] [Related]
5. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM. Alonso R; López-Guerra M; Upshaw R; Bantia S; Smal C; Bontemps F; Manz C; Mehrling T; Villamor N; Campo E; Montserrat E; Colomer D Blood; 2009 Aug; 114(8):1563-75. PubMed ID: 19541822 [TBL] [Abstract][Full Text] [Related]
7. Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. Kojima K; Konopleva M; McQueen T; O'Brien S; Plunkett W; Andreeff M Blood; 2006 Aug; 108(3):993-1000. PubMed ID: 16543464 [TBL] [Abstract][Full Text] [Related]
8. The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Vaseva AV; Marchenko ND; Moll UM Cell Cycle; 2009 Jun; 8(11):1711-9. PubMed ID: 19411846 [TBL] [Abstract][Full Text] [Related]
9. Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins. Faria JR; Yamamoto M; Faria RM; Kerbauy J; Oliveira JS Braz J Med Biol Res; 2006 Mar; 39(3):327-33. PubMed ID: 16501812 [TBL] [Abstract][Full Text] [Related]
10. Constitutively Photomorphogenic 1 Reduces the Sensitivity of Chronic Lymphocytic Leukemia Cells to Fludarabine Through Promotion of Ubiquitin-Mediated P53 Degradation. Fu C; Shi X; Gong Y; Wan Y; Sun Z; Shi H; Wang Z; Marinaccio C; Crispino JD; Xu K Cell Physiol Biochem; 2018; 50(6):2314-2328. PubMed ID: 30423551 [TBL] [Abstract][Full Text] [Related]
12. Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway. Zhou Z; Fang Q; Li P; Ma D; Zhe N; Ren M; Chen B; He Z; Wang J; Zhong Q; Wang J Life Sci; 2019 Sep; 232():116583. PubMed ID: 31226417 [TBL] [Abstract][Full Text] [Related]
13. Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia. Bellosillo B; Villamor N; López-Guillermo A; Marcé S; Bosch F; Campo E; Montserrat E; Colomer D Blood; 2002 Sep; 100(5):1810-6. PubMed ID: 12176904 [TBL] [Abstract][Full Text] [Related]
14. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435 [TBL] [Abstract][Full Text] [Related]
15. AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells. Santidrián AF; González-Gironès DM; Iglesias-Serret D; Coll-Mulet L; Cosialls AM; de Frias M; Campàs C; González-Barca E; Alonso E; Labi V; Viollet B; Benito A; Pons G; Villunger A; Gil J Blood; 2010 Oct; 116(16):3023-32. PubMed ID: 20664053 [TBL] [Abstract][Full Text] [Related]
16. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia. Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680 [TBL] [Abstract][Full Text] [Related]
17. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia. Abo Elwafa R; Abd Elrahman A; Ghallab O Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342 [TBL] [Abstract][Full Text] [Related]
18. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs. Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional upregulation of PUMA modulates endoplasmic reticulum calcium pool depletion-induced apoptosis via Bax activation. Luo X; He Q; Huang Y; Sheikh MS Cell Death Differ; 2005 Oct; 12(10):1310-8. PubMed ID: 15905879 [TBL] [Abstract][Full Text] [Related]
20. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53. Christodoulopoulos G; Fotouhi N; Krajewski S; Reed JC; Alaoui-Jamali M; Panasci L Cancer Lett; 1997 Dec; 121(1):59-67. PubMed ID: 9459175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]